Vous êtes ici

Abattis Bioceuticals Corp.

Liste d'échange: 
CSE
Statut: 
Suspended
Industrie: 
Life Sciences
Symbole: 
ATT
Indice CSE: 
Devise: 

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. Abattis follows strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.

Vous êtes ici

Abattis Bioceuticals Corp. (ATT)

SEDAR Information

Information d'entreprise

Addresse
224 – 970 Burrard Street
Vancouver, BC V6Z 2R4
Canada
Téléphone
778-883-7869
Courriel
news@abattis.com
URL
http://www.abattis.com
Date d’inscription à la cote
Jeudi, décembre 23, 2010
Agent de transfert
Computershare Investor Services Inc.
Relations avec les investisseurs
Hugh Oswald
Vérificateur
DALE MATHESON CARR-HILTON LABONTE LLP

Advertisement

Publicité

Capitalisation

Capitalisation: 
477,804,139
Réservé à l'émission: 
0

Bulletins

Advertisement

Publicité

Latest CSE News

Évènements à venir

2020-07-03-Tech-Tuesday_Transportation_Newsletter_Website

Tech Tuesdays

Mardi, juillet 14, 2020 -
16:15 - 17:00
07-15_Virtual_Industry_Updates_Tech_Strikes_Back_Website

Virtual Industry Updates: Tech Strikes Back

Mercredi, juillet 15, 2020 -
15:00 - 16:15